1910, formerly 1910 Genetics, is an AI drug discovery company from Boston. In 2026 it moved from building its platform to deploying it with pharma partners, under the name ITO.
The brief was credibility in the first meeting with big pharma, and a three-part platform a busy reader understands without going deep into the science. We rebuilt colour, symbol and system from the start, kept the founding vision, and explained the technology one component at a time.
New identity, website, founder film and a full explainer of the ITO platform, delivered in five months. Our second full engagement with the company.
1910 has raised $40M.
Full case: https://www.fiftyseven.co/work/1910
0 likes · 0 views · Nov 4, 2026
New identity, website and platform explainer for 1910, an AI drug discovery company from Boston. 1910 has raised $40M.
